openPR Logo
Press release

Type 1 Diabetes Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PMDA Approvals, Breakthroughs, Clinical and Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies In the Domain

09-19-2022 06:15 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Type 1 Diabetes Therapeutic Pipeline

Type 1 Diabetes Therapeutic Pipeline

As per DelveInsight's assessment, globally, around 80+ key pharma and biotech companies are working on 100+ pipeline drugs in the Type 1 Diabetes therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Type 1 Diabetes Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Type 1 Diabetes Therapeutics Market.

The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).

The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Type 1 Diabetes Pipeline Analysis
The report provides insights into:
The report provides detailed insights about companies that are developing therapies in the Type 1 Diabetes Market.
It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Type 1 Diabetes treatment.
Type 1 Diabetes key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Type 1 Diabetes Drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Type 1 Diabetes market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Request for Sample PDF:
https://www.delveinsight.com/report-store/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

DelveInsight's Report covers around 100+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Type 1 Diabetes Therapeutics Analysis
There are approx. 80+ key companies which are developing therapies for Type 1 Diabetes. Currently, Provention Bio has its Type 1 Diabetes drug candidates in the most advanced stage of clinical development.

Some of the key companies in the Type 1 Diabetes Therapeutics Market include:
Landos Biopharma, Diamyd Medical, Gan&Lee Pharmaceuticals, Zealand Pharma, Kamada, AstraZeneca, Novo Nordisk, Provention Bio, Histogen, Vertex Pharmaceuticals, Panbela Therapeutics, Arecor, Bioprojet, Novartis, ImCyse, Adocia, Anelixis Therapeutics, Tolerion, TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, and many others.

Type 1 Diabetes Emerging Drugs Covered in the report include
• Teplizumab: Prevention Bio
• Emricasan: Histogen
• VX-880: Vertex Pharmaceuticals
And many more

Request the Sample PDF to Get a more in-depth Assessment:
https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr


Table of Content
1. Report Introduction
2. Executive Summary
3. Type 1 Diabetes Current Treatment Patterns
4. Type 1 Diabetes - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Type 1 Diabetes Late Stage Products (Phase-III)
7. Type 1 Diabetes Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Type 1 Diabetes Discontinued Products
13. Type 1 Diabetes Product Profiles
14. Type 1 Diabetes Key Companies
15. Type 1 Diabetes Key Products
16. Dormant and Discontinued Products
17. Type 1 Diabetes Unmet Needs
18. Type 1 Diabetes Future Perspectives
19. Type 1 Diabetes Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.

Request for the Sample PDF (to get a detailed understanding of the TOC, Tables, and Figures included in the report), at:
https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Anuj Rawat
Email: info@delveinsight.com
https://www.delveinsight.com/
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Type 1 Diabetes Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PMDA Approvals, Breakthroughs, Clinical and Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies In the Domain here

News-ID: 2738843 • Views:

More Releases from DelveInsight Business Research

Bartonellosis Market Analysis 2032: Epidemiology, Market Size, Share, Treatment Options, Clinical Trials, Leading Companies & Growth Trends by DelveInsight
Bartonellosis Market Analysis 2032: Epidemiology, Market Size, Share, Treatment …
(New York, USA) DelveInsight's "Bartonellosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Bartonellosis, historical and forecasted epidemiology as well as the Bartonellosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Bartonellosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Bartonellosis market size from 2019 to
Atypical Hemolytic Uremic Syndrome Market Forecasted to Expand by 2032, Projected by DelveInsight | Key Players Include Omeros Corporation, Akari Therapeutics, Alexion Pharmaceuticals, Novartis Pharmaceuticals, Hoffmann-La Roche, and Chugai Pharmaceutical
Atypical Hemolytic Uremic Syndrome Market Forecasted to Expand by 2032, Projecte …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and forecasted epidemiology as well as the Atypical Hemolytic Uremic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Atypical Hemolytic Uremic Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Hyperhidrosis Market Forecast 2032: Epidemiological Insights, Market Dynamics, Therapeutic Innovations, Clinical Trial Landscape by DelveInsight | Leading Companies - Botanix Pharmaceuticals, GSK Plc, Allergan, Brickell Biotech, Atacama
Hyperhidrosis Market Forecast 2032: Epidemiological Insights, Market Dynamics, T …
(New York, USA) DelveInsight's "Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperhidrosis, historical and forecasted epidemiology as well as the Hyperhidrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The report on the Hyperhidrosis market presents up-to-date treatment practices, emerging drugs, the market share of different therapies, and the present and projected size of the Hyperhidrosis market
Projected Expansion in Chronic Lymphocytic Leukemia Market Forecasted by 2032, DelveInsight Predicts | Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG Therapeutics, Bristol Myers Squibb, Novar
Projected Expansion in Chronic Lymphocytic Leukemia Market Forecasted by 2032, D …
(New York, USA) DelveInsight's "Chronic Lymphocytic Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Lymphocytic Leukemia, historical and forecasted epidemiology as well as the Chronic Lymphocytic Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Lymphocytic Leukemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current

All 5 Releases


More Releases for Type

Automotive Electric Vacuum Pump Market By Type Diaphragm Type, Swing Piston Type …
Automatic electric vacuum pump is a device that gets the drive from the camshaft in the engine. It can also be run by alternator shaft in some designs. It’s an added benefit to any engine, which has high performance. The primary function of an automatic electric vacuum pump is to drain out the air from brake booster tank hence creating the vacuum, which in turn can be used for application
Marine Composites Market |By Type |Resin Type|Vessel Type|Fiber Type |Region Ana …
The report includes market segmentation by composites type (metal matrix composite, ceramic matrix composite, polymer matrix composite); polymer matrix composite by fiber type (glass fiber, carbon fiber, others); polymer matrix composite by resin type (polyester, vinyl ester, epoxy, thermoplastic, others); vessel type (power boats, sailboats, cruise ships, others); and region (North America, Europe, APAC, Latin America, MEA). Download Latest Free PDF Sample Brochure of “Marine Composites Market” With Detailed TOC
2-D Materials Market Report 2018: Segmentation by Type (Graphene Type, Borophene …
Global 2-D Materials market research report provides company profile for XG Sciences, Inc, Planar Tech, Garmor, Thomas-swan, Nitronix, 2D Tech Graphene, Abalonyx AS, ACS Material, AVANZARE, BASF SE and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Isoprenol Market Report 2018: Segmentation by Product (Type I, Type II, Others) …
Global Isoprenol market research report provides company profile for Jilin Zhongxin Chemical Group, NHU, Kuraray, BASF and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis
Phenolic Foam Board Market Report 2018: Segmentation by Product (Type 1, Type 2, …
Global Phenolic Foam Board market research report provides company profile for Sekisui Chemical, Jinan Shengquan Group, Tenlead, Guibao, Langfang Sanxing Chemical, Lions, Kingspan Insulation, Asahi Kasei, Unilin (Xtratherm), Hausys and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Bio Pharma Buffer Market By Product Type | Phosphates Type, Acetates Type …
Researchmoz added Most up-to-date research on "Global Bio Pharma Buffer Market By Product Type | Phosphates Type, Acetates Type and TRIS Type" to its huge collection of research reports. This report studies Bio Pharma Buffer in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top